Actinium Pharmaceuticals, Inc. (ATNM) scores 24 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $0.02, representing a 98% premium to fair value. Quantitative score: 42/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.